Abeona Therapeutics Inc. (ABEO) vs SAB Biotherapeutics, Inc. (SABS)
A side-by-side comparison of Abeona Therapeutics Inc. and SAB Biotherapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ABEO
Abeona Therapeutics Inc.
$5.01HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SABS
SAB Biotherapeutics, Inc.
$2.96HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
Total return — ABEO vs SABS
growth of $100 · dividends reinvested · last 6yABEO -89.5% (-31.3%/yr)SABS -96.9% (-44.1%/yr)ABEO compounded faster over this window
ABEO SABS
ABEO vs SABS: by the numbers
- •ABEO is the larger company ($286M vs $270M market cap).
- •Both run net losses; SABS's is the smaller (0.00% vs -246.42% net margin).
Metrics side by side
Valuation
| Metric | ABEO | SABS |
|---|---|---|
| P/S ratio | 11.19 | N/A |
| P/B ratio | 2.23 | 1.26 |
Profitability
| Metric | ABEO | SABS |
|---|---|---|
| Gross margin | 73.68% | 0.00% |
| Operating margin | -1536.91% | 0.00% |
| Net margin | -246.42% | 0.00% |
| ROE | -49.11% | -5.95% |
| ROIC | -49.76% | -31.62% |
Growth (annualized)
| Metric | ABEO | SABS |
|---|---|---|
| Revenue CAGR (5Y) | -10.26% | N/A |
| EPS CAGR (5Y) | N/A | -50.57% |
| Total return CAGR (5Y) | -26.46% | -50.16% |
Frequently asked
- How have ABEO and SABS total returns compared?
- Over the past 5 years, ABEO delivered -26.46% and SABS delivered -50.16% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.